Iris BioTechnologies Welcomes New Board Member and Key Employees - Seite 3

Dr. Ralph Snyderman, often described as the father of personalized medicine, said, "Personalized medicine has the potential to transform our health care system, which consumes almost $3 trillion a year, 80 percent of it for preventable diseases." We believe that the true value of Iris shares will be realized after launching our products for medical, research, and consumer applications. Iris shares are not yet traded on the NASDAQ market. It is currently traded on the OTCBB market where trading volume is thin and stock prices are volatile. During the past year, Iris stock price range was between $0.15 and $4.50. Iris currently has approximately 15 million shares.

Each person is biologically unique. If breast cancer or other disease strikes, who will you call to make sure that you get the right, unique diagnostic in order for your physician to offer you the right medical treatment that will work best for you? We believe that in the future you may think of Iris first.

About Iris BioTechnologies

Iris BioTechnologies Inc. (OTCQB: IRSB) is a life sciences company focused on personalized precision medicine to provide you and your physicians the information to choose the best medical treatment regimen available before treatment begins. Iris enables precision healthcare. We analyze the totality of who you are, by looking at a combination of things including your DNA, family medical history, life style, and environmental exposure. Iris offers the best approach to cancer treatment through (1) actionable integration of molecular profiling with clinical decision-making, (2) precision analysis of potential cancer recurrence and chemotherapy effectiveness, and (3) correlating to targeted therapies and therapies in clinical trials. The Iris Nano-Biochip™ product pipeline includes: Quick Blood Tests, CancerChip™, PrenatalChip™, NeuroChip™ (Alzheimer's and Parkinson diseases), MetabolicChip™ (Diabetes), CardioChip™, and Chips for veterinary, agricultural (e.g., biofuel development), environmental, and other applications. The Iris BioWindows™ artificial intelligence system provides big data and analysis for clinical applications, drug development, and stem cell research. For further information, please visit the Iris website at www.irisbiotech.com.

Iris BioTechnologies Inc.
Simon Chin
408-806-7149
President and CEO
[e-mail]